Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HRT FINANCIAL LP, holds the title of 10% Owner at bioAffinity Technologies, Inc..
On 2026-10-01, the insider transacted 300,463 shares.The shares were transacted at a weighted average price of $7.37 per share, resulting in a total market-relevant value of $2.2M.
HRT FINANCIAL LP (10% Owner) sold $2.2M of $BIAF
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.